SPARC and neoplasm: Notably, these findings are only observational and do not describe the mechanisms through which SPARC might alter T-cell mediated tumour immunity or whether SPARC in this setting mediates its effects through mechanisms outside of the immune system such as tumour angiogenesis or through direct effects on tumour cells.